Angelika Bezan

524 total citations
16 papers, 389 citations indexed

About

Angelika Bezan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Angelika Bezan has authored 16 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Angelika Bezan's work include Renal cell carcinoma treatment (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Sarcoma Diagnosis and Treatment (3 papers). Angelika Bezan is often cited by papers focused on Renal cell carcinoma treatment (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Sarcoma Diagnosis and Treatment (3 papers). Angelika Bezan collaborates with scholars based in Austria, United States and Switzerland. Angelika Bezan's co-authors include Martin Pichler, Armin Gerger, Tatjana Stojaković, Georg C. Hutterer, Karl Pummer, Daniel Krieger, Richard Zigeuner, Michael Stotz, Florian Posch and Joanna Szkandera and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Urology.

In The Last Decade

Angelika Bezan

16 papers receiving 382 citations

Peers

Angelika Bezan

ONCOL

PRM

SURGE

Cui-jian Zhang China

Ji Hyun Lee South Korea

Hideto Ito Japan

Xun Yang China

Katrin Hefler‐Frischmuth Austria

Kiyoshi Kubochi Japan

Anders Christian Larsen Denmark

Dionysios Dellaportas Greece

Jwa Hoon Kim South Korea

M. Sinn Germany

Cui-jian Zhang China

Angelika Bezan

201 ×1.1

ONCOL

92 ×0.6

PRM

97 ×0.7

SURGE

82 ×0.9

47 ×0.7

Citations per year, relative to Angelika Bezan Angelika Bezan (= 1×) peers Cui-jian Zhang

Countries citing papers authored by Angelika Bezan

Since Specialization

Citations

This map shows the geographic impact of Angelika Bezan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelika Bezan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelika Bezan more than expected).

Fields of papers citing papers by Angelika Bezan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelika Bezan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelika Bezan. The network helps show where Angelika Bezan may publish in the future.

Co-authorship network of co-authors of Angelika Bezan

This figure shows the co-authorship network connecting the top 25 collaborators of Angelika Bezan. A scholar is included among the top collaborators of Angelika Bezan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelika Bezan. Angelika Bezan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Stotz, Michael, Sereina A. Herzog, Martin Pichler, et al.. (2017). Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients. Anticancer Research. 37(4). 2011–2018. 9 indexed citations

Absenger, Gudrun, et al.. (2017). ASCO update: lung cancer. memo - Magazine of European Medical Oncology. 10(4). 224–227. 10 indexed citations

Posch, Florian, Jakob M. Riedl, Maria Anna Smolle, et al.. (2017). Benefit of Adjuvant Radiotherapy for Local Control, Distant Metastasis, and Survival Outcomes in Patients with Localized Soft Tissue Sarcoma: Comparative Effectiveness Analysis of an Observational Cohort Study. Annals of Surgical Oncology. 25(3). 776–783. 6 indexed citations

Dandachi, Nadia, Joerg Lindenmann, Luka Brčić, et al.. (2017). Frequency and clinical impact of preoperative circulating tumor cells in resectable non-metastatic lung adenocarcinomas. Lung Cancer. 113. 152–157. 12 indexed citations

Riedl, Jakob M., Florian Posch, Angelika Bezan, et al.. (2017). Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study. BMC Cancer. 17(1). 415–415. 10 indexed citations

Bezan, Angelika, Florian Posch, Ferdinand Ploner, et al.. (2017). Risk stratification for venous thromboembolism in patients with testicular germ cell tumors. PLoS ONE. 12(4). e0176283–e0176283. 32 indexed citations

Posch, Florian, Lukas Leitner, Marko Bergovec, et al.. (2017). Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?. Clinical Orthopaedics and Related Research. 475(5). 1427–1435. 26 indexed citations

Riedl, Jakob M., Florian Posch, Florian Moik, et al.. (2017). Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line setting. Oncotarget. 8(56). 96048–96061. 23 indexed citations

Moik, Florian, Jakob M. Riedl, Thomas Winder, et al.. (2017). Benefit of second-line chemotherapy for advanced biliary tract cancer.. Journal of Clinical Oncology. 35(15_suppl). e15621–e15621. 1 indexed citations

10.

Stotz, Michael, Bernadette Liegl‐Atzwanger, Florian Posch, et al.. (2016). Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection. PLoS ONE. 11(7). e0159448–e0159448. 30 indexed citations

11.

Dalpiaz, Orietta, Martin Pichler, D. Reitz, et al.. (2015). Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma. Journal of Clinical Pathology. 68(7). 547–551. 11 indexed citations

12.

Hutterer, Georg C., Daniel Krieger, Angelika Bezan, et al.. (2015). Preoperative Leucocytosis, Thrombocytosis and Anemia as Potential Prognostic Factors in Non-metastatic Renal Cell Carcinoma.. PubMed. 35(6). 3463–9. 21 indexed citations

13.

Bezan, Angelika, Daniel Krieger, Tatjana Stojaković, et al.. (2015). The Preoperative AST/ALT (De Ritis) Ratio Represents a Poor Prognostic Factor in a Cohort of Patients with Nonmetastatic Renal Cell Carcinoma. The Journal of Urology. 194(1). 30–35. 104 indexed citations

14.

Bezan, Angelika, Armin Gerger, & Martin Pichler. (2014). MicroRNAs in testicular cancer: implications for pathogenesis, diagnosis, prognosis and therapy.. PubMed. 34(6). 2709–13. 47 indexed citations

15.

Hohla, Florian, Georg Hopfinger, Gabriel Rinnerthaler, et al.. (2013). Female gender may predict response to FOLFIRINOX in patients with unresectable pancreatic cancer: A single institution retrospective review. International Journal of Oncology. 44(1). 319–326. 36 indexed citations

16.

Bezan, Angelika, et al.. (2013). Systemic effect of catumaxomab in a patient with metastasized colorectal cancer: a case report. BMC Cancer. 13(1). 618–618. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact